Granted Patent
B2
US 12,286,467 · App. 17/212,403 · Granted Apr 29, 2025
Cell culture media containing combinations of proteins
Inventors:
Steven Clyde Pettit (Junction City, KS); Mary Ann Michelle Fernandez Santos (Junction City, KS); Ning Huang (Junction City, KS)
Assignee:
INVITRIA, INC.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present invention relates to methods of enhancing transfection in cell culture media supplemented with a plant-produced recombinant mammalian transferrin supplement, as well as kits, and methods of using the supplemented cell culture media to improve growth characteristics of cultured cells for transfection.
Claims (15)
1. A method of enhancing transfection efficiency of a cell population during transfection, said method comprising:
a) transfecting a cell population with a nucleic acid molecule in a cell culture media supplemented with a plant-produced recombinant mammalian transferrin related protein, wherein said nucleic acid molecule comprises an expression vector comprising a nucleotide sequence encoding a protein of interest,
wherein said transfection efficiency of said cell population is enhanced relative to a control cell population transfected in cell culture media without said plant-produced recombinant mammalian transferrin related protein supplement.
2. The method of claim 1 , wherein said transfecting comprises culturing said cell population with said nucleic acid molecule in said cell culture media, wherein the plant-produced recombinant mammalian transferrin related protein supplement is added to the cell culture media prior to, during, or immediately after said transfecting step.
3. The method of claim 1 , wherein said protein of interest is a therapeutic protein or an antibody.
4. The method of claim 1 , wherein said nucleotide sequence encoding for the protein of interest is operably linked to an expression control sequence for constitutive or inducible expression in said cell population.
5. The method of claim 1 , wherein said cell culture media comprises at least one additional protein selected from the group consisting of albumin, growth factors, lactoferrin, insulin, growth hormone, fibronectin attachment factor, lamin attachment factor, collagenase, platelet derived growth factor, brain-derived neurotrophic factor, glial-derived neurotrophic factor, thymic factors, haptocorin, lactahedrin, lactoperoxidase, alpha-fetoprotein, immunoglobin, and alpha-lactalbumin.
6. The method of claim 5 , wherein said at least one additional protein is a plant-produced recombinant protein.
7. The method of claim 6 , wherein said at least one additional protein is plant-produced recombinant albumin having less than 1 EU of endotoxin/mg of albumin.
8. The method of claim 7 , wherein the supplement comprises a ratio (wt/wt) of transferrin related protein to albumin of 1 to 5000, to 1 to 0.5.
9. The method of claim 1 , wherein the cell culture media is a serum-free media.
10. The method of claim 1 , wherein the transferrin related protein is lactoferrin or transferrin.
11. The method of claim 1 , wherein said cell population comprises a cell type that is a B-cell, T cell, stem cell, hybridoma, human embryonic kidney line, baby hamster kidney cells, Chinese hamster ovary cell, African green monkey kidney cell, human cervical carcinoma cell, canine kidney cell, human lung cell, human liver cell, or NSO mouse myeloma cell.
12. The method of claim 1 , wherein said transfecting step comprises a technique selected from the group consisting of calcium phosphate transfection, DEAE-dextran mediated transfection, microinjection, cationic lipid-mediated transfection, electroporation, ballistic introduction, and infection of said cell population with viruses or other infectious agents.
13. The method of claim 1 , wherein said transfection efficiency of said cell population transfected in said cell culture media supplemented with said transferrin related protein is enhanced for production of viral vaccines or biologics relative to said control cell population transfected in cell culture media without said plant-produced recombinant mammalian transferrin related protein supplement.
Assignments (3)
CHANGE OF NAME
Recorded Oct 30, 2023
From: VENTRIA BIOSCIENCE INC.
To: INVITRIA, INC.
Reel/Frame 065394/0517 →
MERGER AND CHANGE OF NAME
Recorded Mar 28, 2021
From: VENTRIA BIOSCIENCE; VENTRIA BIOSCIENCE INC.
To: VENTRIA BIOSCIENCE INC.
Reel/Frame 055744/0488 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Mar 28, 2021
From: PETTIT, STEVEN CLYDE; FERNANDEZ SANTOS, MARY ANN MICHELLE; HUANG, NING
To: VENTRIA BIOSCIENCE
Reel/Frame 055744/0493 →
Continuity (5)
Continuation
15188478
· Jun 21, 2016
Provisional Application
61154204
· Feb 20, 2009
References Cited (180)
US 4075197A
· Schuck
· 1978
[cited by applicant]
US 4093612A
· Travis
· 1978
[cited by applicant]
US 4086222A
· Lindquist
· 1978
[cited by applicant]
US 4097473A
· Lewis
· 1978
[cited by applicant]
US 4136094A
· Condie
· 1979
[cited by applicant]
US 4228154A
· Fisher
· 1980
[cited by applicant]
US 5250662A
· Chang
· 1993
[cited by applicant]
US 5650307A
· Sijmons et al.
· 1997
[cited by applicant]
US 5656729A
· Fuluhata
· 1997
[cited by applicant]
US 5677424A
· Rucheton
· 1997
[cited by applicant]
US 5710253A
· Ohtani
· 1998
[cited by applicant]
US 5728553A
· Goodey
· 1998
[cited by applicant]
US 5780593A
· Lihme
· 1998
[cited by applicant]
US 5780594A
· Carter
· 1998
[cited by applicant]
US 5914022A
· Lowry
· 1999
[cited by applicant]
US 5917022A
· Davies
· 1999
[cited by applicant]
US 5985289A
· Potter et al.
· 1999
[cited by applicant]
US 5994507A
· Pilotii
· 1999
[cited by applicant]
US 6001974A
· Demmer
· 1999
[cited by applicant]
US 6034221A
· Berezenko et al.
· 2000
[cited by applicant]
US 6406909B1
· Shibuya
· 2002
[cited by applicant]
US 6586206B1
· Dixit
· 2003
[cited by applicant]
US 6617133B1
· Noda
· 2003
[cited by applicant]
US 6617161B2
· Luyten
· 2003
[cited by applicant]
US 6638740B1
· Goodey
· 2003
[cited by applicant]
US 6733746B2
· Daley
· 2004
[cited by applicant]
US 6787636B1
· Carter
· 2004
[cited by applicant]
US 6890736B1
· Reddy
· 2005
[cited by examiner]
US 6991824B2
· Huang
· 2006
[cited by applicant]
US 7138150B2
· Huang
· 2006
[cited by applicant]
US 7223561B2
· Goodey
· 2007
[cited by applicant]
US 7304208B2
· Huang
· 2007
[cited by applicant]
US 7351801B2
· Belew
· 2008
[cited by applicant]
US 7354902B2
· Legrand
· 2008
[cited by applicant]
US 7417178B2
· Huang
· 2008
[cited by applicant]
US 7423124B2
· Belew
· 2008
[cited by applicant]
US 7531327B2
· Goldenberg
· 2009
[cited by applicant]
US 7531631B2
· Shibata
· 2009
[cited by applicant]
US 7537930B2
· Goldenberg
· 2009
[cited by applicant]
US 7585955B2
· Sang
· 2009
[cited by applicant]
US 20020076747A1
· Price
· 2002
[cited by applicant]
US 20070078851A1
· Grell
· 2007
[cited by applicant]
US 20090170165A1
· Lee
· 2009
[cited by applicant]
US 20090258004A1
· Huang
· 2009
[cited by applicant]
US 20100015713A1
· Deeter
· 2010
[cited by applicant]
US 20130157356A1
· Barnett
· 2013
[cited by applicant]
EP 0947581
· 2004
[cited by applicant]
WO 9836085
· 1998
[cited by applicant]
WO 1998050543
· 1998
[cited by applicant]
WO 200003012
· 2000
[cited by applicant]
WO 200044772
· 2000
[cited by applicant]
WO 0172959
· 2001
[cited by applicant]
WO 02099067
· 2002
[cited by applicant]
WO 2005001094
· 2005
[cited by applicant]
WO 05011367
· 2005
[cited by applicant]
WO 2005056578
· 2005
[cited by applicant]
WO 2006066595
· 2006
[cited by applicant]
WO 2007002762
· 2007
[cited by applicant]
WO 2008009642
· 2008
[cited by applicant]
Okabayshi et al, J. Biochem, Japanese Biochem Soc., 110 (1), 103-110, 1991.
[cited by applicant]
Ravagnan, Nature Cell Biol., 2001, 3, 839-843, 2001.
[cited by applicant]
Wartmann et al., FEMS yeast Res 3 (2), 223-232, 2003.
[cited by applicant]
Millan, A chloroplast transgenic approach to hyper-express and purify Human Serum Albumin, a protein highly susceptible to proteolytic degradation, Plant Biotech. J. 1 71-79, 2003.
[cited by applicant]
Daniell, et al., Vaccine, 23 (15), 1779-1783, 2005.
[cited by applicant]
Ying, et al., Nature, 453, 519-524, 2008.
[cited by applicant]
Barnes, Serum-free Cell Culture: a Unifying Approach, Cell, 1980, vol. 22, 649-655.
[cited by applicant]
Gething, Cell-surface expression of influenza haemagglutinin from a cloned DNA copy of the RNA gene, 1981, Nature 293 620-625.
[cited by applicant]
Welch, Purification of the Major Mammalian Heat Shock Proteins, 1982, J. Biol. Chem. 257 (24) 14949-14959.
[cited by applicant]
Murakami, Growth of hybridoma cells in serum-free medium: Ethanolamine is an essential component, 1982, PNAS 79 1158-1162.
[cited by applicant]
Hashizume, et al, Identification of Lactoferrin as an essential growth factor for human lymphocytic cell lines in serum-free medium, 1983, Biochem. Biophys. Acta. 763 377-382.
[cited by applicant]
Kovar, Serum-free medium for hybridoma and parental myeloma cell cultivation: a novel composition of growth-supporting substances, 1984, Immunol. Lett. 7 339-345.
[cited by applicant]
Amouric, Effect of Lactoferring on the growth of a human colon adenocarcinoma cell line-comparison with transferrin, In vitro 20 (7) 543-548, 1984.
[cited by applicant]
Cole, Antibody production by human × human hybridomas in serum-free medium, J. Imm. Meth. 78 271-278, 1985.
[cited by applicant]
Welch, Rapid Purification of Mammalian 70,000-Dalton stress proteins: Affinity of the proteins for nucleotides, Mal. Cell. Biol. 5(6) 1229-1237, 1985.
[cited by applicant]
Kovar, Serum-free medium for hybridoma and parental myeloma cell cultivation, Methods Enz. 121 277-292, 1986.
[cited by applicant]
Brower, Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium, Cancer Res. 46 798-806, 1986.
[cited by applicant]
Mizrahi, Biologicals produced from animal cells in culture—an overview, Biotechnology Adv. 6(2) 207-220, 1988.
[cited by applicant]
Mizrahi, Media for cultivation of animal cells—an overview, Cytotechnology 1 199-214, 1988.
[cited by applicant]
Butler, Nutritional aspects of the growth of animal cells in culture, J. Biotechnol. 12 97-110, 1989.
[cited by applicant]
Anderson, Structure of Human Lactoferrin: Crystallographic Structure Analysis and Refinement at 2-8 A resolution, J. Mal. Biol. 209 711-734, 1989.
[cited by applicant]
Sijmons, Production of correctly processed human serum albumin in transgenic plants, Biotechnology (NY) 8 217-221, 1990.
[cited by applicant]
Yamada, Stimulation of proliferation and immunoglobulin M production by lactoferrin in human-human and mouse-mouse hybridomas cultures in serum-free conditions, Cytotechnology 3 123-131, 1990.
[cited by applicant]
Lang, Optimization of Growth and secretion of human monoclonal antibodies by hybridomas cultured in serum-free media, Hybridoma 10 (3) 401-408, 1991.
[cited by applicant]
Butler, Nutritional aspects of the growth of animal cells in culture, Mammalian cell Biotechnology, 1991.
[cited by applicant]
Litwin, The growth of Vero cells in suspension as cell-aggregates in serum-free media, Cytotechnology 10(2) 169-74, 1992.
[cited by applicant]
Johnson, Exogenous HSP70 Becomes cell associated, but not internalized, by stressed arterial smooth muscle cells, In vitro Dev. Biol. 29A 807-812, 1993.
[cited by applicant]
Chua, Enhanced IgG production in eRDF media with and without serum, J. Imm. Meth. 167 109-119, 1994.
[cited by applicant]
Carter, Structure of serum albumin, Adv. Pro!. Chem. 45 153-203, 1994.
[cited by applicant]
Matsumoto, Characterization of a human glycopreotein (erythropoietin) produced in cultured tobacco cells, Plant Mol. Biol. 27 1163-1172, 1995.
[cited by applicant]
Kwon, Expression of Active Human Interleikin-6 in Transgenic Tobacco, Mol. Cells 5 (5) 486-492, 1995.
[cited by applicant]
Vianes, Development of an Efficient Serum-Free Semisolid Culture System for the Evaluation of HEmatopoietic Progenitors, J. Hematotherapy 4 105-111.
[cited by applicant]
Hounenou, Exogenous heat shock cognate Hsc70 prevents axotomy-induced death of spinal sensory neurons, Cell Stress & Chap 1 (3) 161-166, 1996.
[cited by applicant]
Bi, Effect of Lactoferring on Proliferation and Differentiation of the Jurkat Human Lymphoblastic T Cell Line, 1997, Arch. Immunol. Ther. Exp.45(4) 315-20.
[cited by applicant]
Guzhova, Effects of exogenous stress protein 70 on the functional properties of human promonocytes through binding to cell surface and internalization, Cell Stress & Chap. 3 (1) 67-77, 1998.
[cited by applicant]
Bai, Multi-metal binding site of serum albumin, J. Inorg. Biochem. 70 (1) 33-39, 1998.
[cited by applicant]
Arakawa, Improvements in human health through production of human milk proteins in transgenic food plants, 1999, Adv. Exp. Med. Biol. 464 149-159.
[cited by applicant]
Wiles, Embryonic Stem Cell Development in a Chemically Defined Medium, 1999, Exp. Cell. Res. 247(1) 241-8.
[cited by applicant]
James, Production and Characterization of Biologically Active Human GM-CSF Secreted by Genetically Modified Plant Cells, Prat. Express. Pur. 19 131-138, 2000.
[cited by applicant]
Leite, Expression of correctly processed human growth hormone in seeds of transgenic plants, 2000, Mol. Breeding 6 47-53.
[cited by applicant]
Chadd, Therapeutic antibody expression technology, Curr. Opin. Biotechnol. 12(2) 188-194, 2001.
[cited by applicant]
Zeilinger, Three-dimensional Co-culture of Primary Human Liver Cells in Bioreactors for In Vitro Drug Studies: Effects of the Initial Cell Quality on the Long-Term Maintenance of Hepatocyte-specific Functions, 2002, Alt…
[cited by applicant]
Blake, Protein Supplementation of Human IVF Culture Media, 2002, J. Assisi. Reprod. Genet. 19(3) 137-143.
[cited by applicant]
Bungum, Recombitant human albumin as protein source in culture media used for IVF: a prospective randomized study, 2002, Reprod. Biomed. Online 4(3) 233-6.
[cited by applicant]
Chuang, Pharmaceutical Strategies Utilizing Recombitant Human Serum Albumin, Pharm Res 19(5) 569-577, 2002.
[cited by applicant]
Huang, Expression of functional recombitant human lysozyme in transgenic rice cell culture, Transgenic Res. 11(3) 229-39, 2002.
[cited by applicant]
Lonnerdal, Expression of Human Milk Proteins in Plants, 2002, J. Am. Coll. Nutr. 21(3) 218S-221S.
[cited by applicant]
Farran, Targeted Expression of human serum albumin to potato tubers, 2002, Transgenic Res. 11(3) 229-39.
[cited by applicant]
Sardana, Biological activity of human granulocyte-macrophage colony stimulating factor is maintained in a fusion with seed glutelin peptide, 2002, Transgenic Res. 11 521-531.
[cited by applicant]
Balaban, Embryo culture as a diagnostic tool, 2003, Reprod. Biomed. Online 7(6) 671-682.
[cited by applicant]
Kwon, Secretory Production of hGM-CSF with a high specific biological activity by transgenic plant cell suspension culture, 2003, Biotech Bioprocess. Eng. 8 135-141.
[cited by applicant]
Suzuki, Expression, Characterization, and Biologic Activity of Recombitant Human Lactoferrin in Rice, 2003, J. Ped. Gast. Nutr. 36 190-199.
[cited by applicant]
Zhang, Expression and production of bioactive human interleukin-18 in transgenic tobacco plants, 2003, Biotechnology Lett. 25 1629-1635.
[cited by applicant]
Newman, Serum-free cell culture—the ethical, scientific, and economic choice, 2003, Biomed. Sci. 941-942.
[cited by applicant]
Conley, Derivation, propagation, and differentiation of human embryonic stem cells, 2004, Int. J. Biochem. Cell. Biol. 36(4) 555-67.
[cited by applicant]
Panahi, Recombinant protein expression plasmids optimized for industrial
[cited by applicant]
Tidwell, Administration of Hsp70 in vivo inhibits motor and sensory neuron degeneration, 2004, Cell Stress & Chap. 9 (1) 88-90.
[cited by applicant]
Wirth, Expression of active human epidermal growth factor (hEGF) in tobacco plants by integrative and non-Integrative systems, 2004, Mol. Breeding 13 23-35.
[cited by applicant]
Baker, Lactoferrin and Iron: structural and dynamic aspects of binding and release, 2004, Biometals 17 209-216.
[cited by applicant]
Sugita, Genetically modified rice seeds accumulating GLP-1 analogue stimulate insulin secretion from a mouse pancreatic beta-cell line, 2005, Febs Lett 579 1085-1088.
[cited by applicant]
Marillonnet, Systemic Agrobacterium tumefaciens-mediated transfection of viral replicons for efficient transient expression in plants, Nature Biotech 23(6) 718-723, 2005.
[cited by applicant]
Huang, Production of human serum albumin by sugar starvation induced promoter and rice cell culture, 2005, Transgenic Res. 14 569-581.
[cited by applicant]
Novoselova, Treatment with extracellular HSP70/HSC70 protein can reduce polyglutamine toxicity and aggregation, 2005, Neurochem 94 597-606.
[cited by applicant]
Keenan, Evaluation of recombinant human transferrin (DeltaFerrin) as an iron chelator in serum-free media for mammalian cell culture, 2006, Cytotechnology 51 29-37.
[cited by applicant]
Invitria, Ventria Bioscience announces third bioprocessing product: cellastim, animal-free recombinant human serum albumin, Press release Jul. 13, 2006.
[cited by applicant]
Wally, A structural comparison of human serum transferrin and human lactoferrin, Biometals 20 249-262, 2007.
[cited by applicant]
Shaner, All in the family:atypical Hsp70 chaperones are conserved modulators of Hsp70 activity, 2007, Cell Stress Chap. 12(1) 1-8.
[cited by applicant]
Wandinger, The Hsp90 Chaperone Machinery, J. Biol. Chem. 283 (27) 18473-18477, 2008.
[cited by applicant]
Brocchieri, Hsp70 genes in the human genome: conservation and differentiation patterns predict a wide array of overlapping and specialized functions, 2008, BMC Evol. Biol. 819 1-20.
[cited by applicant]
Invitria, Zap-CHO Media Supplement Optimizes the Growth kinetics and productivity of CHO cells, Poster, Summer 2008.
[cited by applicant]
Invitria, InVitria's Cellastim delivers superior results in mammalian cell culture, Press release Sep. 25, 2008.
[cited by applicant]
Invitria, InVitria's Cellastim showcased in Nature article, Press release—Oct. 7, 2008.
[cited by applicant]
Ying, The ground state of embryonic stem cell self-renewal, 2008, Nature 453 519-524.
[cited by applicant]
Wong, Lactoferrin is a survival factor for neutrophils in rheumatoid synovial fluid, 2009, Rheumatology 48 39-44.
[cited by applicant]
Blindauer, Structure, properties, and engineering of the major zinc blinding site on human albumin, 2009, J. Biol. Chem. 281(34) 23116-24.
[cited by applicant]
Sarkar, Rice sHsp genes: genomic organization and expression profiling under stress and development, 2009, BMC Genomics 10 393 1-18.
[cited by applicant]
Kampinga, Guidelines for the nomenclature of the human heat shock proteins, 2009, Cell. Stress Chap. 14 105-111.
[cited by applicant]
Petitt, Enhanced growth and productivity of a hybridoma with recombinant human albumin and lactoferrin, 2009, Bioprocess J. 8(1) 50-55.
[cited by applicant]
Invitria, Recombinant Human Serum Albumin Expressed in Plants Improves the Productivity and Growth Kinetics of CHO, Press release, Mar. 2009.
[cited by applicant]
Mantei, et al, 1981, Nature 293 620-625.
[cited by applicant]
Hashizume, 1987, Meth. Enzmol. 147 303-314.
[cited by applicant]
Huang, 2008, In Vitro Cell Dev. Biol. 44 464-471.
[cited by applicant]
Invitria, Press release—Sep. 2009.
[cited by applicant]
Invitria, Press release—Oct. 2009.
[cited by applicant]
Tang, 2010, Wound Rep. Reg. 18 123-131.
[cited by applicant]
Invitria, Poster Jan. 2010.
[cited by applicant]
Office Action in corresponding U.S. Appl. No. 12/708,462, dated Feb. 19, 2013.
[cited by applicant]
Office Action in corresponding U.S. Appl. No. 12/708,462, dated Sep. 18, 2013.
[cited by applicant]
Office Action in corresponding U.S. Appl. No. 12/708,462, dated Jun. 3, 2015.
[cited by applicant]
Office Action in corresponding U.S. Appl. No. 12/708,462, dated Dec. 21, 2015.
[cited by applicant]
Office Action in corresponding U.S. Appl. No. 15/188,478, dated Oct. 16, 2018.
[cited by applicant]
Mawal, 1987, Bioscience Reports, vol. 7, issue 1.
[cited by applicant]
Final Office Action in corresponding U.S. Appl. No. 15/188,478, dated Jun. 17, 2019.
[cited by applicant]
Sharma, et al., “HSP70 Structure, Function, Regulation and Influence on Yeast Prions”, Protein Petp. Lett. 2009, 16(6), 571-581.
[cited by applicant]
Nilausen, “Role of Fatty Acids in Growth-promoting Effect of Serum Albumin on Hamster Cells In Vitro”, J. Cell. Physiol. 1978, 96, 1-14.
[cited by applicant]
Kaufmann, et al., “Heat shock protein 60: Implications for pathogenesis of and protection against bacterial Infections”, Immunological Reviews, 1991, 121, 67-90.
[cited by applicant]
Lin, et al., “Stability of human serum albumin during bioprocessing: Denaturation and aggregation during processing of albumin paste”, Pharmaceutical Research, 2000, 17(4), 391-396.
[cited by applicant]
Morales, et al., “A novel method for removing contaminant Hsp70 molecular chaperones from recombinant proteins,” Protein Science, 2019, 28, 800-807.
[cited by applicant]
Dawson, “A Wealth of Options Choosing an LAL Test Method,” LAL Update, 1995, 13(3).
[cited by applicant]
Joseph, et al., Bacterial expression and purification of interleukin-2 tyrosine kinase: Single step separation of the chaperonin impurity, Protein Expression and Purification, 2008, 60(2), 194-197.
[cited by applicant]
Buytaert-Hoefen, “In Vitria's Portfolio of Cell Culture Ingredients—a Case Study in the Role of Emotions in B2B Marketing,” Fresh Thinking Starts Here, 2008.
[cited by applicant]
U.S. Dept of Health and Human Services, “Guidance for Industry—Sterile Drug Products Produced by Aseptic Processing—Current Good Manufacturing Practice”, 2004.
[cited by applicant]
Matsushita, et al., “Functional analysis of recombinant human serum albumin domains for pharmaceutical applications”, Pharmaceutical Research, 2004, 21(10), 1924-1932.
[cited by applicant]
Lee, et al., “Overexpression of heat shock proteins (HSPs) in CHO cells for extended culture viability and improved recombinant protein production”, Journal of Biotechnology, 2009, 143, 34-43.
[cited by applicant]
Matejtschuk, et al., “Production of human albumin solution: a continually developing colloid”, Br J Anaesth, 2000, 85(6), 887-95.
[cited by applicant]
Bushell, et al., “Cyclic fed-batch culture for production of human serum albumin in Pichia pastoris”, Biotechnology and Bioengineering, 2003, 82(6), 678-683.
[cited by applicant]
Dawson, “The Significance of Endotoxin to Cell Culture and Biotechnology”, LAL Update, 1998, 16(1).
[cited by applicant]
Giddings, et al., “Transgenic plants as factories for biopharmaceuticals”, Nature biotechnology, 2000, 18(11), 1151-1155.
[cited by applicant]
Kirikae, et al., “Endotoxin Contamination in Fetal Bovine Serum and Its Influence on Tumor Necrosis Factor Production by Macrophage-Like Cells J774.1 Cultured in the Presence of the Serum”, Int. J. Immunopharmac., 1997,…
[cited by applicant]
New Century Pharmaceuticals, Inc., “Recombinant Serum Albumin Other Proteins & Antibodies”, 2005 Catalog.
[cited by applicant]
Ashman, et al., “Albumin stimulates cell growth, L-arginine transport, and metabolism to polyamines in human proximal tubular cells”, Kidney Int'l, 2005, 67(5), 1878-89.
[cited by applicant]
Office Action in corresponding U.S. Appl. No. 16/847,337, dated Sep. 1, 2020.
[cited by applicant]